In contrast to that of LOXL1, LOXL2, and LOXL3, the expression of LOXL4 mRNA is consistently reduced across all subtypes of breast cancer, including basal-like, HER2+, luminal A, and luminal B subtypes, in comparison to that in normal breast tissue 20. Here, ERBB2 is linked to breast cancer.